Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
about
Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axisNovel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaTumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategiesIdentification of prostaglandin E2 receptors mediating perinatal masculinization of adult sex behavior and neuroanatomical correlatesRole of cAMP in the promotion of colorectal cancer cell growth by prostaglandin E2.Prostaglandin E2-EP1 and EP2 receptor signaling promotes apical junctional complex disassembly of Caco-2 human colorectal cancer cellsProstanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UKEP1 prostanoid receptor coupling to G i/o up-regulates the expression of hypoxia-inducible factor-1 alpha through activation of a phosphoinositide-3 kinase signaling pathwayAlpha-1 adrenergic receptor transactivates signal transducer and activator of transcription-3 (Stat3) through activation of Src and epidermal growth factor receptor (EGFR) in hepatocytes.Eicosanoids and cancerAntagonism of the prostaglandin E2 EP1 receptor in MDCK cells increases growth through activation of Akt and the epidermal growth factor receptor.mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC.Screening and identification of dietary oils and unsaturated fatty acids in inhibiting inflammatory prostaglandin E2 signaling in fat stromal cells.Secreted PLA2 induces proliferation in astrocytoma through the EGF receptor: another inflammation-cancer link.RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR.Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation.Cytosolic phospholipase A(2)α protects against Fas- but not LPS-induced liver injury.Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cellsHuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration.Hepatitis C virus to hepatocellular carcinoma.Prostanoid EP₁ receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Bioinformatics analysis of the gene expression profile of hepatocellular carcinoma: preliminary results.Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure.The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal CancerTumor-growth-promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targetsbeta-Arrestin mediates beta1-adrenergic receptor-epidermal growth factor receptor interaction and downstream signaling.Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinomaCyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival.Cyclooxygenase-2 prevents fas-induced liver injury through up-regulation of epidermal growth factor receptor.Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells.Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.Nonsteroidal anti-inflammatory drugs modulate cellular glycosaminoglycan synthesis by affecting EGFR and PI3K signaling pathwaysEssential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines.Inhibition of EP2/EP4 signaling abrogates IGF-1R-mediated cancer cell growth: involvement of protein kinase C-θ activation.
P2860
Q24312971-DDEFB626-C83C-485C-B425-753EBE6E67BAQ26767372-1193B90C-DD38-4669-A5E3-86AD592F1E65Q28085631-3901E4F5-B36F-41C5-B25E-EE15207B0F77Q28569205-58FBB2B9-B2BF-4314-9B72-83B17ED5AA57Q30855607-CC693889-3044-476A-9D75-6BBAA06DADD5Q33389486-C6F156CF-74AF-42B9-A4D5-27A0B2AD90E6Q33567396-51A473C8-AA7E-46D6-BD19-938B1688589FQ33642178-42645317-D1F1-4FF5-80A7-AF7BE1DFF82EQ33795154-2915CFC3-79FF-4157-B63A-6AFC74807479Q33890819-6ED6DCED-4BEE-42DB-87CC-8EDD0DACD882Q33919595-F77DB1AE-3E18-46E1-9A67-548389749362Q33966203-73FAB741-232B-4634-8B79-9DAB835AEAACQ34131084-AC653AC2-D08C-4A16-93FB-1479067A471BQ34200876-D93652AE-BA85-40FD-8F4F-A37991D25D87Q34400103-C90C80C6-6F59-4E7A-9AC3-73B41EDCF7B1Q34480613-5D050299-2369-448E-826C-365FEE50DC5BQ35124840-24974366-A625-4EF5-B357-5E0B26694490Q35396873-76B9AE97-B70B-47DE-9C90-6F4EA8A2809EQ35566362-18472B66-26E6-497F-9575-C92C94A52421Q35673201-BB4B8C0F-D409-4F84-AC2D-F08836B63327Q35693003-4C1B4EA1-849E-4649-9771-F159F2AD08FBQ35800315-B9716EDB-718E-437F-8B15-C5475BA6FBAFQ36158964-FBDD1BE1-DECF-4877-9343-A602C1D08925Q36510119-D84B226D-2DB3-4AEE-9FC0-037D85F983FCQ36792873-2200EFEE-34B9-42EF-99D8-BA81D3ECF6CCQ37087444-88DC32EB-3565-4D81-B998-4551E13E136AQ37148157-B662D67B-FD17-45A3-A51E-821B103D3508Q37152015-5309A167-B618-4BFC-8D55-B519DBCE143BQ37339073-73AFB11E-27F8-4816-AC18-95C73801B962Q37351498-536EA89C-EFDA-4830-8C2F-68B035717A71Q37359625-1EB1C61A-69F9-41AF-AC98-AF8F411926A3Q37378968-8CE53FB0-1EA2-4291-90C7-5AEA10A07D37Q37399773-1F60A45D-1BE6-42B0-9D1C-2C4D4C6A2323Q37438352-2542753D-69D3-496C-8F8C-AFCDC8AC8836Q37667936-879B8BED-07D2-4AD3-ABE8-336B186731DCQ37946729-E1683918-3243-4B1F-8BEE-F6AAB0669497Q38161361-B67378D6-2FDC-448F-967A-3231869B7334Q38660494-D8912367-15EE-4A14-BEDB-534E01B27D12Q38885876-CE461F87-FB29-4BDE-9EAD-FCB7C57F62A4Q38914626-7516E98C-6AC3-4B49-B091-C424CD3C21A3
P2860
Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@ast
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@en
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@nl
type
label
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@ast
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@en
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@nl
prefLabel
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@ast
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@en
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@nl
P2093
P356
P1476
Prostaglandin E2 receptor EP1 ...... epatocellular carcinoma cells.
@en
P2093
George K Michalopoulos
P304
P356
10.1002/JCP.20560
P577
2006-04-01T00:00:00Z